Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free ONCSQ Stock Alerts

OncoSec Medical (ONCSQ) Competitors

Compare

ONCSQ vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does OncoSec Medical compare to Ainos?

Ainos (NASDAQ:AIMDW) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

In the previous week, Ainos' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Ainos Neutral
OncoSec Medical Neutral

Ainos has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$124.16KN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
OncoSec Medical N/A N/A N/A

Summary

Ainos beats OncoSec Medical on 1 of the 1 factors compared between the two stocks.

How does OncoSec Medical compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

In the previous week, Alvotech's average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Alvotech Neutral
OncoSec Medical Neutral

Alvotech has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
OncoSec Medical N/A N/A N/A

Summary

Alvotech beats OncoSec Medical on 1 of the 1 factors compared between the two stocks.

How does OncoSec Medical compare to Aravive?

Aravive (NASDAQ:ARAV) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

Aravive is trading at a lower price-to-earnings ratio than OncoSec Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
OncoSec Medical N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Aravive's average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
OncoSec Medical Neutral

Summary

Aravive beats OncoSec Medical on 3 of the 4 factors compared between the two stocks.

How does OncoSec Medical compare to Atlantic Coastal Acquisition Corp. II?

OncoSec Medical (NASDAQ:ONCSQ) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
OncoSec Medical Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

OncoSec Medical and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does OncoSec Medical compare to Avidity Biosciences?

OncoSec Medical (NASDAQ:ONCSQ) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, Avidity Biosciences had 1 more articles in the media than OncoSec Medical. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for OncoSec Medical. OncoSec Medical's average media sentiment score of 0.00 equaled Avidity Biosciences'average media sentiment score.

Company Overall Sentiment
OncoSec Medical Neutral
Avidity Biosciences Neutral

OncoSec Medical has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A

OncoSec Medical has a beta of -30.04, indicating that its stock price is 3,104% less volatile than the S&P 500. Comparatively, Avidity Biosciences has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500.

OncoSec Medical has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. OncoSec Medical's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

Avidity Biosciences has a consensus target price of $69.42, suggesting a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Avidity Biosciences is more favorable than OncoSec Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OncoSec Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32

Summary

Avidity Biosciences beats OncoSec Medical on 7 of the 12 factors compared between the two stocks.

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

Export
MetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$886.55M$6.25B$11.77B
Dividend YieldN/A4.84%2.74%5.26%
P/E Ratio0.001.7129.2527.07
Price / SalesN/A120.63504.6873.47
Price / CashN/A20.0743.3053.90
Price / BookN/A7.609.676.69
Net Income-$34.18M-$4.80M$3.55B$332.64M

OncoSec Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$0.00N/AN/A40
AIMDW
Ainos
N/A$0.11
flat		N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.21
flat		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ONCSQ) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel